Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Validation of Molecular Pathology Codes for the Identification of Mutational Testing in Lung and Colon Cancer

Dados Bibliográficos

ID9102865
AutoresAnil Vachani (0000-0002-3871-8697, University of Pennsylvania, autor correspondente), Yu-Ning Wong (Hematology and Medical Oncology, Fox Chase Cancer Center, Temple University Health System), Yu‐Ning Wong (Fox Chase Cancer Center), Jennifer Israelite (University of Pennsylvania, autor correspondente), Nandita Mitra (0000-0002-7714-3910, Department of Biostatistics and Epidemiology, Perelman School of Medicine), Sakhena Hin (University of Pennsylvania), Lin Yang (0000-0002-1698-6666, University of Pennsylvania), Aaron Smith-McLallen (Independence Blue Cross, Philadelphia, PA), Aaron Smith–McLallen, Katrina Armstrong (0000-0001-5781-5970, Department of Medicine, Massachusetts General Hospital, Boston, MA), Peter W Groeneveld (0000-0002-7374-4292, Leonard Davis Institute of Health Economics, autor correspondente), Andrew J Epstein (0000-0001-5078-6564, Leonard Davis Institute of Health Economics, autor correspondente)
Ano2017
Volume55
Fascículo12
Páginase131-e136
Data de publicação2017-12-01
Peer ReviewedSim
Open AccessNão
TipoARTICLE
PeriódicoMedical Care (JOURNAL)
Identificadores do periódicoISSN: 0025-7079 • E-ISSN: 1537-1948
EditoraOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/mlr.0000000000000484
PMID29135776
OpenAlexW2328211964
IdiomaEN
Referências citadas10

BACKGROUND: Targeted therapy for patients with lung and colon cancer based on tumor molecular profiles is an important cancer treatment strategy, but the impact of gene mutation tests on cancer treatment and outcomes in large populations is not clear. In this study, we assessed the accuracy of an algorithm to identify tumor mutation testing in administrative claims data during a period before test-specific Current Procedural Terminology codes were available. MATERIALS AND METHODS: We used Pennsylvania Cancer Registry data to select patients with lung or colon cancer diagnosed between 2007 and 2011 who were treated at the University of Pennsylvania Health System, and we obtained their administrative claims. A combination of Current Procedural Terminology laboratory codes (stacking codes) was used to identify potential tumor mutation testing in the claims data. Patients' electronic medical records were then searched to determine whether tumor mutation testing actually had been performed. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated. RESULTS: An algorithm using stacking codes had moderate sensitivity (86% for lung cancer and 81% for colon cancer) and high specificity (98% for lung cancer and 96% for colon cancer). Sensitivity and specificity did not vary significantly during 2007-2011. In patients with lung cancer, PPV was 98% and NPV was 92%. In patients with colon cancer, PPV was 96% and NPV was 83%. CONCLUSIONS: An algorithm using stacking codes can identify tumor mutation testing in administrative claims data among patients with lung and colon cancer with a high degree of accuracy

Algorithm · Biology · Cancer · Colorectal cancer · Current Procedural Terminology · Gene · KRAS · Lung cancer · Mutation · Cancer Genomics and Diagnostics · Computer Science · Genetic factors in colorectal cancer · Genetics · Internal Medicine · Lung Cancer Treatments and Mutations · Medicine · Oncology · Surgery

Velocidade de citaçãohistorical
Altamente citadoNão
Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae